Stock CPH CIPHER PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Delayed Toronto S.E.
Other stock markets
 10:03:33 2024-04-29 am EDT 		5-day change 1st Jan Change
8.55 CAD +0.59% Intraday chart for Cipher Pharmaceuticals Inc. +1.91% +54.33%
Mar. 15 Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Mar. 14 Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cipher Pharmaceuticals Brief: Names Bryan Jacobs as New CFO, Effective August 15; Earlier Reported Q2 Diluted EPS of US$0.08
MT
Cipher Pharmaceuticals Inc. Announces Appointment of Bryan Jacobs as Chief Financial Officer
CI
John Mull Decides Not to Stand for Re-Election as Director of Cipher Pharmaceuticals Inc
CI
Cipher Pharmaceuticals Inc. Approves the Appointment of Cathy Steiner as Director
CI
Cipher Pharmaceuticals Inc. Announces Executive Changes; Provides Earnings Guidance for the Second Quarter Ended June 30, 2019
CI
Cipher Pharmaceuticals Inc. Announces Board Changes
CI
Cipher Pharmaceuticals Inc. Appoints Mr. Craig Mull to the Board of Directors
CI
Cipher Pharmaceuticals Inc. Announces Executive Changes
CI
Cipher Pharmaceuticals Inc. Names Michael Milloy as Vice President, Canadian Commercial Operations
CI
Cipher Pharmaceuticals Inc. Appoints Diane Gajewczyk as Vice President, Scientific and Medical Affairs
CI
Cipher Pharmaceuticals Inc. Elects Laurence Terrisse-Rulleau as Director
CI
Cipher Pharmaceuticals Inc. Announces Executive Changes
CI
Cipher Pharmaceuticals Inc. Elects Arthur Deboeck as Director
CI
Cipher Pharmaceuticals Appoints Robert D. Tessarolo as President and Chief Executive Officer, Effective April 17, 2017
CI
Cipher Pharmaceuticals Inc. Announces Change of Chief Executive Officer
CI
Cipher Pharmaceuticals Announces Executive Changes
CI
Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors
CI
Cipher Pharmaceuticals Inc. Appoints Ralph Bohrer as President & General Manager of U.S. Business
CI
Cipher Pharmaceuticals Inc. Announces Executive Appointments and Promotions
CI
Cipher Pharmaceuticals Inc. Announces Executive Promotions
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. News Cipher Pharmaceuticals Inc.
  5. Insiders